Related Experiment Video

Updated: Aug 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

Impact of antibiotic restrictions: the physician's perspective

D Price1

  • 1Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, UK. d.price@abdn.ac.uk

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|July 11, 2006
PubMed

Insights

Reducing antibiotic prescribing may increase pneumonia deaths, particularly in lower respiratory tract infections. Further research is needed to understand antibiotic restrictions

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Global efforts aim to curb inappropriate antibiotic prescribing due to rising antimicrobial resistance.
  • The impact of antibiotic restrictions on infection complications remains under-investigated.
  • Randomized clinical trials face limitations in patient numbers and generalizability for this research question.

Purpose of the Study:

  • To systematically investigate the effects of antibiotic restrictions on infection complications.
  • To examine the association between reduced antibiotic prescribing and patient outcomes.
  • To inform global antibiotic prescribing practices and identify at-risk populations.

Main Methods:

  • Utilized observational data from the UK.
  • Analyzed trends in antibiotic prescribing for lower respiratory tract infections.
  • Correlated prescribing changes with pneumonia mortality rates.

Main Results:

  • UK data show a link between reduced antibiotic prescribing for lower respiratory tract infections and increased pneumonia mortality.
  • Suggests potential adverse outcomes associated with antibiotic stewardship measures.

Conclusions:

  • Further international studies are essential to validate these findings across different countries and infections.
  • Findings highlight the need to carefully evaluate the consequences of antibiotic stewardship on patient outcomes.
  • Targeted care for at-risk groups may be necessary to mitigate potential negative effects.

More Related Videos

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes08:58

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes

Published on: March 3, 2023

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...